Report Detail

Pharma & Healthcare Global Non-steroidal Anti-inflammatory Drugs(NSAID) Market Insights, Forecast to 2025

  • RnM2428342
  • |
  • 17 April, 2019
  • |
  • Global
  • |
  • 117 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global Non-steroidal Anti-inflammatory Drugs(NSAID) Market Insights, Forecast to 2025

Table of Contents

    1 Study Coverage

    • 1.1 Non-steroidal Anti-inflammatory Drugs(NSAID) Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Growth Rate by Product
      • 1.4.2 Aspirin
      • 1.4.3 Ibuprofen
      • 1.4.4 Naproxen
      • 1.4.5 Nabumetone
      • 1.4.6 Others
    • 1.5 Market by End User
      • 1.5.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size Growth Rate by End User
      • 1.5.2 Back Pain Treatment
      • 1.5.3 Osteoarthritis Treatment
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Market Size
      • 2.1.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue 2014-2025
      • 2.1.2 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales 2014-2025
    • 2.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Growth Rate by Regions
      • 2.2.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Regions
      • 2.2.2 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Manufacturers
      • 3.1.1 Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Manufacturers
      • 3.1.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Market Share by Manufacturers
      • 3.1.3 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Market Concentration Ratio (CR5 and HHI)
    • 3.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Manufacturers
      • 3.2.1 Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Manufacturers (2014-2019)
      • 3.2.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Share by Manufacturers (2014-2019)
    • 3.3 Non-steroidal Anti-inflammatory Drugs(NSAID) Price by Manufacturers
    • 3.4 Non-steroidal Anti-inflammatory Drugs(NSAID) Manufacturing Base Distribution, Product Types
      • 3.4.1 Non-steroidal Anti-inflammatory Drugs(NSAID) Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Non-steroidal Anti-inflammatory Drugs(NSAID) Product Type
      • 3.4.3 Date of International Manufacturers Enter into Non-steroidal Anti-inflammatory Drugs(NSAID) Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Product
    • 4.2 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Product
    • 4.3 Non-steroidal Anti-inflammatory Drugs(NSAID) Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Breakdown Data by End User

    6 North America

    • 6.1 North America Non-steroidal Anti-inflammatory Drugs(NSAID) by Countries
      • 6.1.1 North America Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Countries
      • 6.1.2 North America Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Non-steroidal Anti-inflammatory Drugs(NSAID) by Product
    • 6.3 North America Non-steroidal Anti-inflammatory Drugs(NSAID) by End User

    7 Europe

    • 7.1 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) by Countries
      • 7.1.1 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Countries
      • 7.1.2 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) by Product
    • 7.3 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs(NSAID) by Countries
      • 8.1.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Countries
      • 8.1.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs(NSAID) by Product
    • 8.3 Asia Pacific Non-steroidal Anti-inflammatory Drugs(NSAID) by End User

    9 Central & South America

    • 9.1 Central & South America Non-steroidal Anti-inflammatory Drugs(NSAID) by Countries
      • 9.1.1 Central & South America Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Countries
      • 9.1.2 Central & South America Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Non-steroidal Anti-inflammatory Drugs(NSAID) by Product
    • 9.3 Central & South America Non-steroidal Anti-inflammatory Drugs(NSAID) by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs(NSAID) by Countries
      • 10.1.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Sales by Countries
      • 10.1.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs(NSAID) by Product
    • 10.3 Middle East and Africa Non-steroidal Anti-inflammatory Drugs(NSAID) by End User

    11 Company Profiles

    • 11.1 Bayer
      • 11.1.1 Bayer Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Bayer Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Bayer Non-steroidal Anti-inflammatory Drugs(NSAID) Products Offered
      • 11.1.5 Bayer Recent Development
    • 11.2 Novacap
      • 11.2.1 Novacap Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Novacap Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Novacap Non-steroidal Anti-inflammatory Drugs(NSAID) Products Offered
      • 11.2.5 Novacap Recent Development
    • 11.3 Abbott
      • 11.3.1 Abbott Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Abbott Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Abbott Non-steroidal Anti-inflammatory Drugs(NSAID) Products Offered
      • 11.3.5 Abbott Recent Development
    • 11.4 Pfizer
      • 11.4.1 Pfizer Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Pfizer Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Pfizer Non-steroidal Anti-inflammatory Drugs(NSAID) Products Offered
      • 11.4.5 Pfizer Recent Development
    • 11.5 Geri-Care Pharmaceuticals
      • 11.5.1 Geri-Care Pharmaceuticals Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs(NSAID) Products Offered
      • 11.5.5 Geri-Care Pharmaceuticals Recent Development
    • 11.6 Perrigo Company
      • 11.6.1 Perrigo Company Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Perrigo Company Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Perrigo Company Non-steroidal Anti-inflammatory Drugs(NSAID) Products Offered
      • 11.6.5 Perrigo Company Recent Development
    • 11.7 Kopran
      • 11.7.1 Kopran Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Kopran Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Kopran Non-steroidal Anti-inflammatory Drugs(NSAID) Products Offered
      • 11.7.5 Kopran Recent Development
    • 11.8 Merck Sharp & Dohme
      • 11.8.1 Merck Sharp & Dohme Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Merck Sharp & Dohme Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Merck Sharp & Dohme Non-steroidal Anti-inflammatory Drugs(NSAID) Products Offered
      • 11.8.5 Merck Sharp & Dohme Recent Development
    • 11.9 Sun Pharmaceutical Industries
      • 11.9.1 Sun Pharmaceutical Industries Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs(NSAID) Products Offered
      • 11.9.5 Sun Pharmaceutical Industries Recent Development
    • 11.10 Glaxo Smith Kline
      • 11.10.1 Glaxo Smith Kline Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Glaxo Smith Kline Non-steroidal Anti-inflammatory Drugs(NSAID) Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Glaxo Smith Kline Non-steroidal Anti-inflammatory Drugs(NSAID) Products Offered
      • 11.10.5 Glaxo Smith Kline Recent Development
    • 11.11 Reddy Pharmaceuticals
    • 11.12 Johnson & Johnson

    12 Future Forecast

    • 12.1 Non-steroidal Anti-inflammatory Drugs(NSAID) Market Forecast by Regions
      • 12.1.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Forecast by Regions 2019-2025
    • 12.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Market Forecast by Product
      • 12.2.1 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Sales Forecast by Product 2019-2025
      • 12.2.2 Global Non-steroidal Anti-inflammatory Drugs(NSAID) Revenue Forecast by Product 2019-2025
    • 12.3 Non-steroidal Anti-inflammatory Drugs(NSAID) Market Forecast by End User
    • 12.4 North America Non-steroidal Anti-inflammatory Drugs(NSAID) Forecast
    • 12.5 Europe Non-steroidal Anti-inflammatory Drugs(NSAID) Forecast
    • 12.6 Asia Pacific Non-steroidal Anti-inflammatory Drugs(NSAID) Forecast
    • 12.7 Central & South America Non-steroidal Anti-inflammatory Drugs(NSAID) Forecast
    • 12.8 Middle East and Africa Non-steroidal Anti-inflammatory Drugs(NSAID) Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Non-steroidal Anti-inflammatory Drugs(NSAID) Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Non-steroidal Anti-inflammatory Drugs(NSAID) market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Non-steroidal Anti-inflammatory Drugs(NSAID) market based on company, product type, end user and key regions.

      This report studies the global market size of Non-steroidal Anti-inflammatory Drugs(NSAID) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Non-steroidal Anti-inflammatory Drugs(NSAID) in these regions.
      This research report categorizes the global Non-steroidal Anti-inflammatory Drugs(NSAID) market by top players/brands, region, type and end user. This report also studies the global Non-steroidal Anti-inflammatory Drugs(NSAID) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Bayer
      Novacap
      Abbott
      Pfizer
      Geri-Care Pharmaceuticals
      Perrigo Company
      Kopran
      Merck Sharp & Dohme
      Sun Pharmaceutical Industries
      Glaxo Smith Kline
      Reddy Pharmaceuticals
      Johnson & Johnson

      Market size by Product
      Aspirin
      Ibuprofen
      Naproxen
      Nabumetone
      Others
      Market size by End User
      Back Pain Treatment
      Osteoarthritis Treatment
      Other

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Non-steroidal Anti-inflammatory Drugs(NSAID) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Non-steroidal Anti-inflammatory Drugs(NSAID) market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Non-steroidal Anti-inflammatory Drugs(NSAID) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Non-steroidal Anti-inflammatory Drugs(NSAID) submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Non-steroidal Anti-inflammatory Drugs(NSAID) are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Non-steroidal Anti-inflammatory Drugs(NSAID) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Non-steroidal Anti-inflammatory Drugs(NSAID) . Industry analysis & Market Report on Non-steroidal Anti-inflammatory Drugs(NSAID) is a syndicated market report, published as Global Non-steroidal Anti-inflammatory Drugs(NSAID) Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Non-steroidal Anti-inflammatory Drugs(NSAID) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,117.69
      4,676.54
      6,235.38
      3,472.34
      5,208.51
      6,944.68
      420,030.00
      630,045.00
      840,060.00
      268,557.90
      402,836.85
      537,115.80
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report